Early response to vunakizumab and its baseline predictors in patients with moderate-to-severe plaque psoriasis: a post hoc analysis of a phase-III trial. - Yu, Yangyiyi; Zeng, Jinrong; Lu, Jianyun (Journal of Dermatological Treatment, 2025)